查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420965

流感诊断市场（测试类型：RT-PCR 测试、快速流感诊断测试、病毒培养、免疫萤光测定、血清学测试等）- 全球行业分析、规模、份额、增长、趋势和预测，2023-2031 年

Influenza Diagnostics Market (Test Type: RT-PCR Tests, Rapid Influenza Diagnostic Tests, Viral Culture, Immunofluorescence Assays, Serological Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 172 Pages | 商品交期: 2-10个工作天内

价格

流感诊断市场 - 报告范围

TMR 关于全球流感诊断市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球流感诊断市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球流感诊断市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解流感诊断市场。

市场概况
2023年市场价值 13亿美元
2031 年市场价值 20 亿美元
CAGR 5.6%

该报告深入探讨了全球流感诊断市场的竞争格局。全球流感诊断市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球流感诊断市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 疾病流行病学
  • 报销场景
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按流感病毒类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按流感病毒类型，2017-2031
    • A型
    • B型
  • 市场吸引力分析：按流感病毒类型

第 7 章：全球市场分析与预测：按测试类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依测试类型，2017-2031
    • RT-PCR 测试
    • 流感快速诊断检验 (RIDT)
    • 病毒文化
    • 免疫萤光分析
    • 血清学测试
    • 其他（LAMP、SAMBA 等）
  • 市场吸引力分析：按测试类型

第 8 章：全球市场分析与预测：依产品类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2017-2031
    • 试剂盒和试剂
    • 乐器
    • 其他的
  • 市场吸引力分析：按产品类型

第 9 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院
    • 诊断中心
    • 其他（学术研究机构等）
  • 市场吸引力分析：按最终用户

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • 3M
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Becton, Dickinson and Company
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Goldsite Diagnostics Inc.
    • Hologic, Inc.
    • DiaSorin SpA
    • Meridian Bioscience, Inc.
    • QuidelOrtho Corporation
    • SA Scientific Ltd.
    • Sekisui Diagnostics
    • Siemens Healthineers
    • Thermo Fisher Scientific
Product Code: TMRGL17435

Influenza Diagnostics Market - Scope of Report

TMR's report on the global influenza diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global influenza diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global influenza diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the influenza diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.3 Bn
Market Value in 2031US$ 2 Bn
CAGR5.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global influenza diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global influenza diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global influenza diagnostics market.

The report delves into the competitive landscape of the global influenza diagnostics market. Key players operating in the global influenza diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global influenza diagnostics market profiled in this report.

Key Questions Answered in Global influenza diagnostics Market Report:

  • What is the sales/revenue generated by influenza diagnostics across all regions during the forecast period?
  • What are the opportunities in the global influenza diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Influenza Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global influenza diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global influenza diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global influenza diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Influenza Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Influenza Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Reimbursement Scenario
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Influenza Diagnostics Market Analysis and Forecast, by Flu Virus Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 6.3.1. Type A
    • 6.3.2. Type B
  • 6.4. Market Attractiveness Analysis, by Flu Virus Type

7. Global Influenza Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Test Type, 2017-2031
    • 7.3.1. RT-PCR Tests
    • 7.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 7.3.3. Viral Culture
    • 7.3.4. Immunofluorescence Assays
    • 7.3.5. Serological Tests
    • 7.3.6. Others (LAMP, SAMBA, etc.)
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global Influenza Diagnostics Market Analysis and Forecast, by Product Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Product Type, 2017-2031
    • 8.3.1. Kits & Reagents
    • 8.3.2. Instrument
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Product Type

9. Global Influenza Diagnostics Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others (academics & research institutes, etc.)
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Influenza Diagnostics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Influenza Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 11.2.1. Type A
    • 11.2.2. Type B
  • 11.3. Market Value Forecast, by Test Type, 2017-2031
    • 11.3.1. RT-PCR Tests
    • 11.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 11.3.3. Viral Culture
    • 11.3.4. Immunofluorescence Assays
    • 11.3.5. Serological Tests
    • 11.3.6. Others (LAMP, SAMBA, etc.)
  • 11.4. Market Value Forecast, by Product Type, 2017-2031
    • 11.4.1. Kits & Reagents
    • 11.4.2. Instrument
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Others (academics & research institutes, etc.)
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Flu Virus Type
    • 11.7.2. By Test Type
    • 11.7.3. By Product Type
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Influenza Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 12.2.1. Type A
    • 12.2.2. Type B
  • 12.3. Market Value Forecast, by Test Type, 2017-2031
    • 12.3.1. RT-PCR Tests
    • 12.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 12.3.3. Viral Culture
    • 12.3.4. Immunofluorescence Assays
    • 12.3.5. Serological Tests
    • 12.3.6. Others (LAMP, SAMBA, etc.)
  • 12.4. Market Value Forecast, by Product Type, 2017-2031
    • 12.4.1. Kits & Reagents
    • 12.4.2. Instrument
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Centers
    • 12.5.3. Others (academics & research institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Flu Virus Type
    • 12.7.2. By Test Type
    • 12.7.3. By Product Type
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Influenza Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 13.2.1. Type A
    • 13.2.2. Type B
  • 13.3. Market Value Forecast, by Test Type, 2017-2031
    • 13.3.1. RT-PCR Tests
    • 13.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 13.3.3. Viral Culture
    • 13.3.4. Immunofluorescence Assays
    • 13.3.5. Serological Tests
    • 13.3.6. Others (LAMP, SAMBA, etc.)
  • 13.4. Market Value Forecast, by Product Type, 2017-2031
    • 13.4.1. Kits & Reagents
    • 13.4.2. Instrument
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Others (academics & research institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Flu Virus Type
    • 13.7.2. By Test Type
    • 13.7.3. By Product Type
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Influenza Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 14.2.1. Type A
    • 14.2.2. Type B
  • 14.3. Market Value Forecast, by Test Type, 2017-2031
    • 14.3.1. RT-PCR Tests
    • 14.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 14.3.3. Viral Culture
    • 14.3.4. Immunofluorescence Assays
    • 14.3.5. Serological Tests
    • 14.3.6. Others (LAMP, SAMBA, etc.)
  • 14.4. Market Value Forecast, by Product Type, 2017-2031
    • 14.4.1. Kits & Reagents
    • 14.4.2. Instrument
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Others (academics & research institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Flu Virus Type
    • 14.7.2. By Test Type
    • 14.7.3. By Product Type
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Influenza Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Flu Virus Type, 2017-2031
    • 15.2.1. Type A
    • 15.2.2. Type B
  • 15.3. Market Value Forecast, by Test Type, 2017-2031
    • 15.3.1. RT-PCR Tests
    • 15.3.2. Rapid Influenza Diagnostic Tests (RIDTs)
    • 15.3.3. Viral Culture
    • 15.3.4. Immunofluorescence Assays
    • 15.3.5. Serological Tests
    • 15.3.6. Others (LAMP, SAMBA, etc.)
  • 15.4. Market Value Forecast, by Product Type, 2017-2031
    • 15.4.1. Kits & Reagents
    • 15.4.2. Instrument
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Diagnostic Centers
    • 15.5.3. Others (academics & research institutes, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Flu Virus Type
    • 15.7.2. By Test Type
    • 15.7.3. By Product Type
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. 3M
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Abbott
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. F. Hoffmann-La Roche Ltd.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Becton, Dickinson and Company
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. BIOMERIEUX
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bio-Rad Laboratories, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Goldsite Diagnostics Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Hologic, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. DiaSorin S.p.A.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Meridian Bioscience, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. QuidelOrtho Corporation
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. SA Scientific Ltd.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Sekisui Diagnostics
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Siemens Healthineers
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview
    • 16.3.15. Thermo Fisher Scientific
      • 16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.15.2. Product Portfolio
      • 16.3.15.3. Financial Overview
      • 16.3.15.4. SWOT Analysis
      • 16.3.15.5. Strategic Overview

List of Tables

  • Table 01: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 02: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 03: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 04: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 08: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 09: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 10: North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 13: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 14: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 18: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 19: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 20: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 23: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 24: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 25: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Flu Virus Type, 2017-2031
  • Table 28: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 29: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 30: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Influenza Diagnostics Market Size, by Flu Virus Type, 2022
  • Figure 02: Global Influenza Diagnostics Market Share (%), by Flu Virus Type, 2022
  • Figure 03: Global Influenza Diagnostics Market Size, by Test Type, 2022
  • Figure 04: Global Influenza Diagnostics Market Share (%), by Test Type, 2022
  • Figure 05: Global Influenza Diagnostics Market Size, by Product Type, 2022
  • Figure 06: Global Influenza Diagnostics Market Share (%), by Product Type, 2022
  • Figure 07: Global Influenza Diagnostics Market Size, by End-user, 2022
  • Figure 08: Global Influenza Diagnostics Market Share (%), by End-user, 2022
  • Figure 09: Global Influenza Diagnostics Market, by Region (2022 and 2031)
  • Figure 10: Global Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 11: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 12: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022
  • Figure 13: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2031
  • Figure 14: Global Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 15: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 16: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022
  • Figure 17: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2031
  • Figure 18: Global Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 19: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 20: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022
  • Figure 21: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2031
  • Figure 22: Global Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 23: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022
  • Figure 25: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2031
  • Figure 26: Global Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031
  • Figure 28: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2022
  • Figure 29: Global Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Region, 2031
  • Figure 30: Global Influenza Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 31: North America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: North America Influenza Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 33: North America Influenza Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 34: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 35: North America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 36: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 37: North America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-31
  • Figure 38: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 39: North America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-31
  • Figure 40: North America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 41: North America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 42: Europe Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 43: Europe Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 44: Europe Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 45: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 46: Europe Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 47: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 48: Europe Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 49: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 50: Europe Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 51: Europe Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 52: Europe Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 53: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 54: Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 57: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 58: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 59: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 60: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 61: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 62: Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 63: Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 64: Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 65: Latin America Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 66: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 68: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 69: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 70: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 71: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 72: Latin America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 73: Latin America Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 74: Latin America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 75: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 76: Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 77: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 78: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Flu Virus Type, 2022 and 2031
  • Figure 79: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Flu Virus Type, 2023-2031
  • Figure 80: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
  • Figure 81: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 82: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 83: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 84: Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 85: Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031